Wound treating stem cell gel for patients with diabetic foot ulcers
from Physical Therapy Products
A recent Phase II clinical trial of a wound healing stem cell gel found that the product promoted healing in 73 percent of patients with diabetic foot ulcers, compared to 46 percent treated with a placebo. The gel, DSC127, is an analog of a naturally occurring peptide, Angiotensin. It has been shown to increase keratinocyte proliferation, increase extracellular matrix production, and increase vascularization.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063